CARBAMAZEPINE MONOTHERAPY IN EPILEPTIC OUT-PATIENTSBO ANDERSEN E; PHILBERT A; GORDON KLEE J et al.1983; ACTA NEUROLOGICA SCANDINAVICA. SUPPLEMENTUM; ISSN 0065-1427; DNK; DA. 1983; VOL. 67; NO 94; PP. 29-34; BIBL. 4 REF.Article

MYOCARDIAL DAMAGE AFTER ANDROCTONUS CRASSICAUDA CRASSICAUDA STINGFLUGELMAN MY; NAPARSTEK V; BRAVERMAN AJ et al.1982; ISRAEL JOURNAL OF MEDICAL SCIENCES; ISSN 0021-2180; ISR; DA. 1982; VOL. 18; NO 4; PP. 503-504; BIBL. 7 REF.Article

ACTIVE METABOLITES IN ANTIEPILEPTIC THERAPY: REFLECTIONS ON A PHARMACOLOGICAL JOKERHVIDBERG EF.1983; ACTA NEUROLOGICA SCANDINAVICA. SUPPLEMENTUM; ISSN 0065-1427; DNK; DA. 1983; VOL. 67; NO 94; PP. 9-13; BIBL. 19 REF.Article

ENDOCRINE FUNCTION AND ANTIEPILEPTIC TREATMENTLUHDORF K.1983; ACTA NEUROLOGICA SCANDINAVICA. SUPPLEMENTUM; ISSN 0065-1427; DNK; DA. 1983; VOL. 67; NO 94; PP. 15-19; BIBL. 37 REF.Article

PATHOPHYSIOLOGY BEHIND ANTICONVULSANT OSTEOMALACIACHRISTIANSEN C; RODBRO P; TJELLESEN L et al.1983; ACTA NEUROLOGICA SCANDINAVICA. SUPPLEMENTUM; ISSN 0065-1427; DNK; DA. 1983; VOL. 67; NO 94; PP. 21-28; BIBL. 23 REF.Article

MECHANISM OF RESISTANCE TO THE ONCOLYTIC C-NUCLEOSIDE 2-BETA -D RIBOFURANOSYLTHIAZOLE-4-CARBOXAMIDE (NSC-286193)JAYARAM HN; COONEY DA; GLAZER RI et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 15; PP. 2557-2560; BIBL. 6 REF.Article

ENZYMES OF SALVAGE AND DE NOVO PATHWAYS OF SYNTHESIS OF PYRIMIDINE NUCLEOTIDES IN HUMAN COLORECTAL ADENOCARCINOMASAHMED NK; HAGGITT RC; WELCH AD et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 15; PP. 2485-2488; BIBL. 17 REF.Article

SENSITIVITY OF AML LEUCOCYTES IN CULTURE TO L-METHIONINASETAUTT J; LETOWSKA M; HAY M et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 15; PP. 2553-2556; BIBL. 9 REF.Article

TRUNCAL ATAXIA IN CHRONIC ANTICONVULSANT TREATMENT ASSOCIATION WITH DRUG-INDUCED FOLATE DEFICIENCYMUNOZ GARCIA D; DEL SER T; BERMEJO F et al.1982; JOURNAL OF THE NEUROLOGICAL SCIENCES; ISSN 0022-510X; NLD; DA. 1982; VOL. 55; NO 3; PP. 305-311; BIBL. 24 REF.Article

LES EFFETS SECONDAIRES DES MEDICAMENTS ANTIEPILEPTIQUES: DONNEES RECENTESMAUGUIERE F; COURJON J.1983; LYON MEDICAL; ISSN 0024-7790; FRA; DA. 1983; VOL. 249; NO 3; PP. 59Article

TERATOGENICITY AND LETHALITY OF HYDANTOIN DERIVATIVES IN THE MOUSE: STRUCTURE-TOXICITY RELATIONSHIPSBROWN NA; SHULL G; KAO J et al.1982; TOXICOLOGY AND APPLIED PHARMACOLOGY; ISSN 0041-008X; USA; DA. 1982; VOL. 64; NO 2; PP. 271-288; BIBL. 48 REF.Article

EFFECTS OF N-DI-PROPYLACETATE ON AGGRESSIVE BEHAVIOR AND BRAIN GABA LEVEL IN ISOLATED MICESIMLER S; PUGLISI ALLEGRA S; MANDEL P et al.1983; PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR; ISSN 0091-3057; USA; DA. 1983; VOL. 18; NO 5; PP. 717-720; BIBL. 22 REF.Article

INHIBITION OF INITIATION OF TRANSLATION IN L1210 CELLS BY 8-AZAGUANINERIVEST RS; IRWIN D; MANDEL HG et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 15; PP. 2505-2511; BIBL. 49 REF.Article

ABSENCE D'EFFETS DU VALPROATE DE SODIUM SUR LE CYCLE OESTRAL DE LA RATTEBRUGUEROLLE B; JADOT G; VALLI M et al.1982; COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES; ISSN 0037-9026; FRA; DA. 1982; VOL. 176; NO 3; PP. 359-363; ABS. ENG; BIBL. 16 REF.Article

PRECLINICAL STUDIES ON HUMAN INSULIN. II: GENERAL PHARMACOLOGICAL STUDIESJOERGENSEN KD; WOLFFBRANDT KH; WEIS JU et al.1983; ACTA PHARMACOLOGICA ET TOXICOLOGICA; ISSN 0001-6683; DNK; DA. 1983; VOL. 52; NO 4; PP. 268-272; BIBL. 6 REF.Article

ALPHA-SUBSTITUTED GAMMA -BUTYROLACTONES: NEW CLASS OF ANTICONVULSANT DRUGSKLUNK WE; MCKEON AC; COVEY DF et al.1982; SCIENCE; ISSN 0036-8075; USA; DA. 1982; VOL. 217; NO 4564; PP. 1040-1042; BIBL. 12 REF.Article

ACUTE AND CHRONIC EFFECTS OF PHENYTOIN ON FIXED-RATIO PERFORMANCE OF PIGEONSKRAFFT K; POLING A.1982; PHARMACOL., BIOCHEM. BEHAV.; ISSN 0091-3057; USA; DA. 1982; VOL. 16; NO 5; PP. 843-846; BIBL. 11 REF.Article

VERAPAMIL RESPONSIVE REENTRANT VENTRICULAR TACHYCARDIA: A CASE REPORT WITH ELECTROPHYSIOLOGICAL INVESTIGATIONHASIN Y; KRIWISKY M; GOTSMAN MS et al.1981; ISRAEL JOURNAL OF MEDICAL SCIENCES; ISSN 0021-2180; ISR; DA. 1981; VOL. 18; NO 4; PP. 499-502; BIBL. 12 REF.Article

ANTIEPILEPTIC DRUGS AND TERATOGENESIS: HOW SHOULD PATIENTS, DOCTORS AND HEALTH AUTHORITIES BE COUNSELLED.LAUE FRIIS M.1983; ACTA NEUROLOGICA SCANDINAVICA. SUPPLEMENTUM; ISSN 0065-1427; DNK; DA. 1983; VOL. 67; NO 94; PP. 39-43; BIBL. 16 REF.Article

ANTIHYPOXIC ACTION OF SOME PSYCHOTROPIC DRUGSNIKOLOVA M.1982; DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH; ISSN 0378-6501; CHE; DA. 1982; VOL. 8; NO 4; PP. 461-465; BIBL. 22 REF.Article

CARBAMAZEPINEABOUL ENEIN HY; AL BADR AA.1980; ANAL. PROFILES DRUG SUBST.; ISSN 0099-5428; USA; DA. 1980; VOL. 9; PP. 87-106; BIBL. 39 REF.Article

DIPHENYLHYDANTOIN EXCRETION IN THE SEMEN OF TREATED EPILEPTICSCOHN DF; HOMONNAI ZT; PAZ GP et al.1982; ISRAEL JOURNAL OF MEDICAL SCIENCES; ISSN 0021-2180; ISR; DA. 1982; VOL. 18; NO 4; PP. 509-511; BIBL. 8 REF.Article

Synthesis of DL-Hydroxybenzenamides as AnticonvulsantsMEZA-TOLEDO, Sergio E; YASUTAKE-KIMOTO, Liliana; ALCALA-RENTERIA, Martha et al.Arzneimittel-Forschung. 2008, Vol 58, Num 3, pp 105-110, issn 0004-4172, 6 p.Article

LES EFFETS SECONDAIRES DES MEDICAMENTS ANTIEPILEPTIQUES (DONNEES RECENTES). III: EFFETS DES ANTIEPILEPTIQUES SUR LE SYSTEME IMMUNITAIREMAUGUIERE F; COURJON J.1983; LYON MEDICAL; ISSN 0024-7790; FRA; DA. 1983; VOL. 249; PP. 463-467; ABS. ENG; BIBL. 42 REF.Article

BACLOFEN: ITS EFFECT ON SEIZURE FREQUENCYTERRENCE CF; FROMM GH; ROUSSAN MS et al.1983; ARCHIVES OF NEUROLOGY (CHICAGO); ISSN 0003-9942; USA; DA. 1983; VOL. 40; NO 1; PP. 28-29; BIBL. 13 REF.Article